Abstract
Mind wandering has been linked to a wide range of psychiatric conditions, yet most studies have examined these associations in isolation. Given the substantial comorbidity across the psychopathological spectrum, it remains unclear whether elevated mind wandering reflects a general marker of psychopathology or a more specific attentional-control deficit shared across symptom dimensions. To address this, we adopted a dimensional, transdiagnostic approach in a non-clinical sample ( N = 376), simultaneously modeling seven symptom dimensions: ADHD, depression, obsessive-compulsive tendencies, schizotypy, autistic traits, hypomania, and eating disorder symptoms. At the bivariate level, mind wandering correlated positively with all symptom dimensions. However, when the substantial shared variance across dimensions was accounted for in both frequentist and Bayesian multivariate regression models, only ADHD symptoms emerged as a unique predictor (β = 0.53; BF□□ > 1000), with all remaining predictors yielding negligible unique contributions and Bayes factors supporting the null hypothesis. These findings suggest that previously reported associations between mind wandering and diverse psychopathological symptom dimensions largely reflect a shared liability with ADHD-related attentional dysregulation, rather than disorder-specific mechanisms. This positions mind wandering as a marker of attentional dysregulation more closely tied to ADHD symptomatology than to general psychopathological burden.
Full text
1,593 characters
· extracted from
oa-doi-fallback
· click to expand
Abstract
Mind wandering has been linked to a wide range of psychiatric conditions, yet most studies have examined these associations in isolation. Given the substantial comorbidity across the psychopathological spectrum, it remains unclear whether elevated mind wandering reflects a general marker of psychopathology or a more specific attentional-control deficit shared across symptom dimensions. To address this, we adopted a dimensional, transdiagnostic approach in a non-clinical sample (N = 376), simultaneously modeling seven symptom dimensions: ADHD, depression, obsessive-compulsive tendencies, schizotypy, autistic traits, hypomania, and eating disorder symptoms. At the bivariate level, mind wandering correlated positively with all symptom dimensions. However, when the substantial shared variance across dimensions was accounted for in both frequentist and Bayesian multivariate regression models, only ADHD symptoms emerged as a unique predictor (β = 0.53; BF□□ > 1000), with all remaining predictors yielding negligible unique contributions and Bayes factors supporting the null hypothesis. These findings suggest that previously reported associations between mind wandering and diverse psychopathological symptom dimensions largely reflect a shared liability with ADHD-related attentional dysregulation, rather than disorder-specific mechanisms. This positions mind wandering as a marker of attentional dysregulation more closely tied to ADHD symptomatology than to general psychopathological burden.
Competing Interest Statement
The authors have declared no competing interest.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.